Pelvic Congestion Syndrome and Endometriosis
VES
Ultrasound Evaluation of the Prevalence of Pelvic Congestion Syndrome in Patients With Endometriosis
1 other identifier
observational
160
1 country
1
Brief Summary
The pelvic congestion syndrome (PCS) is a complex and multifactorial condition associated with inflammatory and hormonal etiophatogenesis similar to the endometriosis. Furthermore, both pathologies share same clinical symptoms as chronic pelvic pain and dyspareunia. Our hypothesis is that PCS prevalence is higher in patients with endometriosis than in those without clinical or ultrasound signs of endometriosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Dec 2018
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2018
CompletedFirst Posted
Study publicly available on registry
June 26, 2018
CompletedStudy Start
First participant enrolled
December 14, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2019
CompletedJune 12, 2019
June 1, 2019
7 months
June 11, 2018
June 11, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Incidence of pelvic congestive syndrome in patients with endometriosis
Comparison of pelvic congestive syndrome symptoms and ultrasounds characteristics, assessed by standard gynecological examination (bimanual gynecological examination and gynecological ultrasounds), between patients with endometriosis (Group A) and without clinical or ultrasound signs of endometriosis.
1 day, first medical examination
Secondary Outcomes (4)
Correlation between type of pain and pelvic congestive syndrome
1 day, first medical examination
Correlation between pain severity and pelvic congestive syndrome
1 day, first medical examination
Correlation between symptoms and ongoing medical treatments
1 day, first medical examination
Correlation between history of pelvic surgery and pelvic congestive syndrome
1 day, first medical examination
Study Arms (2)
Group A: endometriosis
assessment of pain symptoms at first medical examination; assessment of pelvic vascular insufficiency signs.
Group B: no endometriosis
assessment of pain symptoms at first medical examination; assessment of pelvic vascular insufficiency signs.
Interventions
First medical examination consists of collection of medical history and standard gynecological examination (bimanual gynecological examination and abdominopelvic ultrasounds). Data regarding age, Body Mass Index, ongoing hormone therapy and pelvic pain symptoms, assessed according to Visual Analogue Scale (VAS) (from 0= no pain to 10= unbearable pain), are collected. The presence of perineal or lower limb varices and the presence and localization of evoked pain at bimanual gynecological examination are also evaluated.
Assessment of pelvic vascular insufficiency in conducted using abdominopelvic ultrasounds, according to the following parameters: * Ovarian vein diameter \<4mm * Slow ovarian blood flow (\<3cm/sec) * Retrograde blood flow * Dilated arcuate veins communicating with pelvic varices The presence of pelvic varices is evaluated qualitatively as normal, moderate and serious This evaluation includes the study of uterine and ovarian vessels, using different techniques: * Standard 2D study, to measure vessels diameter * Vascular doppler study, to evaluate flow direction and blood speed * 3D color study, for a three- dimensional reconstruction of vessels and a more accurate qualitative assessment of the congestion degree.
Eligibility Criteria
Patients undergoing routine gynecological examinations in our center are included in the study.
You may qualify if:
- Obtaining Informed Consent
- Nulliparity
- Clinical or ultrasounds signs of endometriosis
- Obtaining Informed Consent
- Nulliparity
You may not qualify if:
- Menopause
- Actual or previous pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Gynecology and Physiopathology of Human Reproductive Unit, University of Bologna, S. Orsola-Malpighi Hospital
Bologna, BO, 40138, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
June 11, 2018
First Posted
June 26, 2018
Study Start
December 14, 2018
Primary Completion
July 1, 2019
Study Completion
August 1, 2019
Last Updated
June 12, 2019
Record last verified: 2019-06
Data Sharing
- IPD Sharing
- Will not share